CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Yang, Xianfeng ^a   Tan, Ming Zhen ^a   Qiu, Anqi ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HIPPOCAMPUS; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; LATERAL VENTRICLES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; ORGAN SIZE; PROGNOSIS; SUPPORT VECTOR MACHINES;

EID: 84871312937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047406     Document Type: Article

References (36)

1. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, et al. (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 257-262.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269.
3. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, et al. (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-279.
4. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 280-292.
5. Ferrarini L, Palm WM, Olofsen H, van der Landen R, van Buchem MA, et al. (2008) Ventricular shape biomarkers for Alzheimer's disease in clinical MR images. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 59: 260-267.
6. Ferrarini L, Frisoni GB, Pievani M, Reiber JH, Ganzola R, et al. (2009) Morphological hippocampal markers for automated detection of Alzheimer's disease and mild cognitive impairment converters in magnetic resonance images. Journal of Alzheimer's disease: JAD 17: 643-659.
7. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9: 119-128.
8. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, et al. (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132: 1355-1365.
9. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ, (2011) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32: 2322 e2319-2327.
10. Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, et al. (2009) Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 72: 1519-1525.
11. Qiu A, Younes L, Miller MI, Csernansky JG, (2008) Parallel transport in diffeomorphisms distinguishes the time-dependent pattern of hippocampal surface deformation due to healthy aging and the dementia of the Alzheimer's type. Neuroimage 40: 68-76.
12. Costafreda SG, Dinov ID, Tu Z, Shi Y, Liu CY, et al. (2011) Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56: 212-219.
13. Westman E, Muehlboeck JS, Simmons A, (2012) Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage.
14. Cui Y, Liu B, Luo S, Zhen X, Fan M, et al. (2011) Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 6: e21896.
15. Cardenas VA, Du AT, Hardin D, Ezekiel F, Weber P, et al. (2003) Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia. Neurobiol Aging 24: 537-544.
16. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, et al. (2006) Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol 5: 828-834.
17. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, et al. (2006) Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 63: 693-699.
18. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM, et al. (1996) Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 119 (Pt 6):: 2001-2007.
19. Wang L, Swank JS, Glick IE, Gado MH, Miller MI, et al. (2003) Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage 20: 667-682.
20. Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, et al. (2006) 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 129: 2867-2873.
21. Alves Fda S, Figee M, Vamelsvoort T, Veltman D, de Haan L, (2008) The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Psychopharmacol Bull 41: 121-132.
22. Qiu A, Fennema-Notestine C, Dale AM, Miller MI, Initiative AsDN, (2009) Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. Neuroimage 45: 656-661.
23. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, et al. (2002) Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain. Neuron 33: 341-355.
24. Miller MI, Qiu A, (2009) The emerging discipline of Computational Functional Anatomy. Neuroimage 45: S16-39.
25. Qiu A, Brown T, Fischl B, Ma J, Miller MI, (2010) Atlas Generation for Subcortical and Ventricular Structures with Its Applications in Shape Analysis. IEEE Transactions on Image Processing 19: 1539-1547.
26. Qiu A, Miller MI, (2008) Multi-structure network shape analysis via normal surface momentum maps. Neuroimage 42: 1430-1438.
27. Qiu A, Brown T, Fischl B, Ma J, Miller MI, (2010) Atlas generation for subcortical and ventricular structures with its applications in shape analysis. IEEE Trans Image Process 19: 1539-1547.
28. Tenenbaum JB, de Silva V, Langford JC, (2000) A global geometric framework for nonlinear dimensionality reduction. Science 290: 2319-2323.
29. Yang X, Goh A, Qiu A, (2011) Locally Linear Diffeomorphic Metric Embedding (LLDME) for surface-based anatomical shape modeling. Neuroimage 56: 149-161.
30. Vapnik VN (1995) The Nature of Statistical Learning Theory: Springer.
31. Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, et al. (2002) Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 13: 1939-1943.
32. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, et al. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65: 403-413.
33. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, et al. (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 73: 294-301.
34. Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Trojanowski JQ, et al. (2010) Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 75: 143-151.
35. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, et al. (2010) Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging.
36. Zhang D, Wang Y, Zhou L, Yuan H, Shen D, (2011) Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 55: 856-867.